We further identified that high-RiboSis-activity subpopulations drive microenvironmental immunosuppression via the MIF-(CD74+CD44) axis: CellChat analysis validated this axis promotes myeloid cell polarization toward M2-type tumor-associated macrophages while impairing T-cell activation. The gene discussed is CD44; the disease is neoplasm.